Entry Point Capital, LLC Ptc Therapeutics, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 4,055 shares of PTCT stock, worth $174,202. This represents 0.18% of its overall portfolio holdings.
Number of Shares
4,055
Previous 2,261
79.35%
Holding current value
$174,202
Previous $65.8 Million
88.53%
% of portfolio
0.18%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding PTCT
# of Institutions
221Shares Held
79.4MCall Options Held
122KPut Options Held
207K-
Vanguard Group Inc Valley Forge, PA8.97MShares$386 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$353 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$334 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$318 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$299 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.07B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...